Crestline Management’s SeaStar Medical ICU Stock Holding History

Crestline Management’s Portfolio ICU Stock Details ICU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-204	Closed	-$523K	–	186
2022 Q3	$523K	Hold	204	–	–	0.07%	140
2022 Q2	$518K	Hold	204	–	–	0.07%	162
2022 Q1	$516K	Hold	204	–	–	0.06%	167
2021 Q4	$512K	Hold	204	–	–	0.04%	160
2021 Q3	$512K	Hold	204	–	–	0.05%	151
2021 Q2	$504K	Buy	+204	New	+$505K	0.04%	117

Other funds holding ICU

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

CCFM

Cohen & Co Financial Management New York $18.3M AUM 73.48% 1-Year Est. Return

SWA

SFMG Wealth Advisors Plano, Texas $1.48B AUM 15.85% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Crestline Management's ICU Position: Q4 2022 in Review

Crestline Management sold out of SeaStar Medical (ICU) in Q4 2022, closing a stake of 204 shares — an estimated $523K sold.

Crestline Management first reported a position in ICU in Q2 2021 and held it in 6 quarters. The position peaked at $523K in Q3 2022. 8 funds tracked by Wall St. Rank hold ICU as of Q4 2022.

Crestline Management reported no remaining SeaStar Medical position as of Q4 2022 after selling out during the quarter.
Crestline Management sold 204 SeaStar Medical shares in Q4 2022, an estimated $523K.
Crestline Management first reported a position in SeaStar Medical in Q2 2021 and held it in 6 quarters.
Crestline Management's SeaStar Medical position peaked at $523K in Q3 2022.
8 funds tracked by Wall St. Rank held SeaStar Medical as of Q4 2022.

Based on Crestline Management's 13F filing for Q4 2022, filed 13 Feb 2023.